-
Sidra Medicine Pioneers New Pediatric Treatment Protocol for Infant with Congenital Hyperinsulinism
28 January 2024, Doha, Qatar – In a world first, Sidra Medicine, a member of Qatar Foundation, has pioneered a new treatment protocol for a young infant with congenital hyperinsulinism. The findings h…
Continue Reading..... -
Sidra Medicine Study Reveals Impact of Highly Processed Foods on Brain Metabolism and Sense of Smell
24 January 2024, Doha, Qatar – Researchers at Sidra Medicine, a member of Qatar Foundation, in collaboration with teams from the Universidade Federal do Rio Grande do Sul (Brazil) and Monell Chemical …
Continue Reading..... -
Sidra Medicine Study Recognized as Key Advancement in Cancer Microbiome Field
21 January 2024, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, is proud to announce that one of its research studies published in Nature Medicine in May 2023, has been featured in the Ye…
Continue Reading..... -
Sidra Medicine and Hamad Medical Corporation to Co-host QPEM 2024
08 January 2024, Doha, Qatar – Sidra Medicine and Hamad Medical Corporation will co-host the 8th Qatar Pediatric Emergency Conference (QPEM) from 19 to 21 January 2024. QPEM 2024 aims is to provide hi…
Continue Reading.....